NCT01873508View on ClinicalTrials.gov

A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

RO4917523

Fast release MR capsule, single dose

DRUG

RO4917523

Target release MR capsule, single dose

DRUG

RO4917523

Slow release MR capsule, single dose

DRUG

RO4917523

\[13C\]-labeled tracer dose i.v.

Trial Locations (1)

08053

Marlton

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01873508 - A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers | Biotech Hunter | Biotech Hunter